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Summary
Background.  —  Ventricular  septal  defect  (VSD)  after  acute  myocardial  infarction  is  a  cata-
strophic event.defect; Aims.  —  We  describe  our  multicentre  experience  of  a  defect  closure  strategy  that  combined
Surgical  closure; surgery and  transcatheter  closure.
Interventional
catheterization
Methods.  —  Data  were  obtained  by  retrospective  chart  review.
Results.  —  Twenty  patients  (mean  age,  67  years)  from  three  centres  were  studied.  Median  time
from myocardial  infarction  to  VSD  was  6  (range,  3—9)  days.  Acute  cardiogenic  shock  occurred
Abbreviations: AMI, acute myocardial infarction; PMI-VSD, post-acute myocardial infarction ventricular septal defect; VSD, ventricular
septal defect.
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in  12  (60%)  patients.  Median  defect  diameter  by  echocardiography  was  18  (range,  12—28)  mm.
Median time  to  ﬁrst  surgical  or  percutaneous  closure  was  18  (range,  4—96)  days.  Twenty-seven
procedures  were  performed  in  the  20  patients.  Surgical  closure  was  undertaken  in  14  patients
and contraindicated  in  eight,  six  of  whom  underwent  percutaneous  closure;  the  other  two,
after reconsideration,  proceeded  to  surgical  closure.  No  procedural  complications  occurred
with percutaneous  closure.  Percutaneous  closure  patients  were  older  than  surgical  patients  (75
vs. 64  years;  P  =  0.01)  and  had  a  higher  mean  logistic  EuroSCORE  (87%  vs.  67%;  P  =  0.02).  Rates  of
residual  shunt  and  mortality  did  not  differ  between  surgical  and  percutaneous  patients  (P  =  0.12
and 0.3,  respectively).  Those  who  underwent  early  VSD  closure  (<  21  days  after  myocardial
infarction)  had  higher  rates  of  residual  shunt  (P  =  0.09)  and  mortality  (P  =  0.01),  irrespective  of
closure strategy.  The  mortality  rate  was  also  higher  after  early  percutaneous  closure  (P  =  0.001),
but not  after  early  surgery.  Finally,  predicted  mortality  (logistic  EuroSCORE)  was  higher  than
hospital mortality  (≤  30  days)  in  our  patient  population  (75%  vs.  30%;  P  =  0.01).
Conclusion.  —  Vigorous  pursuit  of  closure  of  post-myocardial  infarction  VSD  with  a  sequential
surgical and/or  percutaneous  approach  is  recommended  for  improved  outcomes.
© 2015  Published  by  Elsevier  Masson  SAS.
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Résumé
Contexte.  —  Les  communications  interventriculaires  post-infarctus  myocardique  ont  un  pronos-
tic catastrophique.
Objectifs.  —  Nous  décrivons  notre  expérience  multicentrique  combinant  la  chirurgie  et  le
cathétérisme  interventionnel.
Méthodes.  —  Les  données  ont  été  obtenues  par  l’étude  rétrospective  des  dossiers  des  patients.
Résultats. — Vingt  patients  dans  3  centres  ont  été  étudiés  à  l’âge  moyen  de  67  ans.  Le  délai
médian entre  la  survenue  de  l’infarctus  du  myocarde  et  le  diagnostic  de  la  communication
interventriculaire  était  de  6  (3—9)  jours.  Un  choc  cardiogénique  est  survenu  dans  12  cas  (60  %).
Le diamètre  médian  du  défaut  septal  à  l’échocardiographie  était  de  18  (12—28)  mm.  Le  délai
médian de  la  première  fermeture  de  la  communication  interventriculaire  était  de  18  (4—96)
jours. Au  total,  27  procédures  ont  été  réalisées  chez  20  patients  dont  une  fermeture  chirur-
gicale dans  14  cas.  Cette  dernière  étant  contre-indiquée  chez  8  patients,  une  fermeture  par
cathétérisme  a  été  pratiquée  dans  6  cas,  les  2  derniers  patients  initialement  contre-indiqués  à  la
chirurgie  ayant  ﬁnalement  été  fermés  chirurgicalement  après  rediscussion  de  leur  opérabilité.
Aucune complication  n’est  survenue  lors  des  cathétérismes.  Les  patients  dont  la  communi-
cation interventriculaire  a  été  fermée  par  cathétérisme  étaient  plus  âgés  que  les  patients
chirurgicaux  (75  vs  64  ans  ;  p  =  0,01)  et  l’EuroSCORE  logistique  pour  le  groupe  cathétérisme  était
signiﬁcativement  plus  élevé,  reﬂétant  une  population  plus  grave  (87  %  vs  67  %  ;  p  =  0,02).  Le
taux de  shunts  résiduels  et  la  mortalité  ne  différaient  pas  signiﬁcativement  entre  les  2  groupes
chirurgie  et  cathétérisme  (p  =  0,12  et  0,3,  respectivement).  Les  patients  dont  la  communica-
tion interventriculaire  a  été  fermée  précocement  (<  21  jours  après  l’infarctus)  avaient  taux  de
shunts résiduels  et  de  décès  plus  important  (p  =  0,09  et  0,01,  respectivement)  quelle  que  soit  la
stratégie de  fermeture.  Le  décès  était  plus  fréquent  après  une  fermeture  percutanée  (p  =  0,001)
précoce  mais  pas  après  la  chirurgie  précoce.  Enﬁn,  la  mortalité  prédictive  (EuroSCORE  logis-
tique) était  de  75  %,  signiﬁcativement  plus  élevée  que  la  mortalité  hospitalière  à  30  %  dans
notre population  de  patients  (p  =  0,01).
Conclusion.  —  La  poursuite  d’une  prise  en  charge  agressive  de  fermeture  des  communica-
tions interventriculaires  post-infarctus,  combinant  de  manière  séquentielle  la  chirurgie  et  le
cathétérisme  interventionnel,  est  recommandée  pour  continuer  d’améliorer  le  pronostic.
© 2015  Publié  par  Elsevier  Masson  SAS.
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cackgroundschaemic  ventricular  septal  rupture  after  acute  myocardial
nfarction  (AMI)  is  a  catastrophic  event.  The  resulting  ven-
ricular  septal  defect  (VSD)  imposes  an  acute  left-to-right
T
d
rhunt,  precipitating  or  exaggerating  cardiogenic  shock  and
ompounding  the  preexisting  cardiac  disease  burden  [1].
he  incidence  of  post-AMI  VSD  (PMI-VSD)  appears  to  have
eclined  in  recent  times  to  0.2%  [2,3]; however,  mortality
emains  high  in  patients  with  PMI-VSD  [1,4—6].  Management
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ization  was  performed  in  13  (65%)  patients.  One  (5%)Post-infarction  ventricular  septal  defects  
of  these  patients  presents  complex  challenges.  Urgent  sur-
gical  repair  of  PMI-VSD  was  ﬁrst  proposed  in  the  early
1980s,  because  nearly  100%  mortality  was  reported  with
medical  management  alone  [7].  The  American  Heart  Asso-
ciation/American  College  of  Cardiology  practice  guidelines
recommend  urgent  surgical  repair  of  PMI-VSD  as  a  class  I
indication  [8].  However,  early  surgical  repair  (from  3  days
to  within  4  weeks  after  AMI)  has  a  52%  operative  in-
hospital  mortality  rate,  while  delayed  surgical  repair  has
an  overall  in-hospital  mortality  rate  of  8%  [9].  Yet  there
is  often  an  urgent  need  to  proceed  with  PMI-VSD  clo-
sure  to  avert  a  fatality,  despite  early  surgical  closure
being  associated  with  a  high  incidence  (20%)  of  resid-
ual  shunt,  leaving  an  additional  disease  burden  [2]. Thus
the  concept  of  an  ‘optimal  time’  for  PMI-VSD  closure  is
misleading.
In  the  past  decade,  percutaneous  device  closure  of  PMI-
VSD  has  emerged  as  an  alternative  strategy,  with  a  high
procedural  success  rate  [10—12].  A  management  strategy
that  considers  application  of  both  techniques  has  not  been
explored  extensively  to  date.  It  has  been  suggested  that
defects  <  15  mm  should  be  treated  with  percutaneous  ther-
apy,  either  as  a  temporary  strategy,  to  stabilize  the  patient
until  a  deﬁnitive  surgical  repair  can  be  accomplished,  or
as  a  deﬁnitive  therapy  [13].  However,  percutaneous  clo-
sure  of  larger  defects  is  feasible  [14].  Residual  shunts  after
surgical  closure,  which  are  not  uncommon,  can  undergo
percutaneous  closure  [15,16].  We  believe  that  a  manage-
ment  algorithm  that  applies  surgical  and/or  percutaneous
closure  of  PMI-VSD  for  the  best  potential  management
of  a  patient  needs  to  be  delineated.  In  this  report,  we
describe  our  experience  of  a  management  algorithm  that
applies  surgical  and/or  percutaneous  closure  of  PMI-VSD
for  the  best  management  of  any  patient.  ‘Best’  manage-
ment  was  deﬁned  as  amelioration  or  elimination  of  the
haemodynamic  burden  related  to  the  shunt  resulting  from
PMI-VSD.
Methods
In  our  practice,  we  offered  surgical  closure  of  PMI-VSD
in  accordance  with  the  American  College  of  Cardiol-
ogy/American  Heart  Association  recommendations  [8].
Percutaneous  closure  was  pursued  when  surgical  closure  was
contraindicated  or  declined  by  the  patient.  Additionally,  we
offered  percutaneous  closure  in  patients  with  residual  shunt
after  surgical  closure.
A  retrospective  review  of  charts  was  conducted  at
the  participating  centres,  to  identify  patients  presenting
with  AMI  who  developed  PMI-VSD  between  April  2006
and  May  2012.  Data  pertaining  to  clinical  presentation,
co-morbidities,  echocardiography,  haemodynamic  ﬁndings,
clinical  course,  technical  details  of  surgical  or/and  transcat-
heter  closure,  acute  outcome  and  the  most  recent  follow-up
were  obtained.
Surgical  closure  was  performed  under  cardiopulmonary
bypass.  The  defect  was  approached  through  the  left  ventri-
cle,  except  in  posterior  PMI-VSD,  in  which  case  an  incision
was  made  into  the  posterior  left  ventricular  infarct.  The
double-patch  concept  was  applied.  After  patch  closure
of  PMI-VSD,  patch  closure  of  the  approach  incision  was
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erformed.  Small  defects  were  closed  by  application  of  a
ingle  patch.  Associated  large  ventricular  aneurysm  under-
ent  an  endoexclusion  [17].
Percutaneous  closure  was  carried  out  when  there  was  a
ontraindication  to  surgical  closure  or  for  patient  prefer-
nce.  Percutaneous  closure  was  performed  under  ultrasound
uidance  (transoesophageal  and  transthoracic)  in  accor-
ance  with  the  techniques  described  previously  [10—16].
ntibiotic  prophylaxis  was  administered  in  the  form  of  a
ingle  dose  of  cefamandole  (1.5  g).  Heparin  was  admin-
stered  in  standard  doses.  Patients  with  heparin-induced
hrombocytopoenia  received  intravenous  anti-factor  Xa
2500  units).  Clopidogrel  and  aspirin  were  given  to  all
atients.
Statistical  analysis:  PASW  Statistics  17.0  (SPSS,  Inc.,
hicago,  IL,  USA)  was  used  for  statistical  analysis.  Nomi-
al  variables  are  expressed  as  numbers  and  percentages,
nd  were  compared  by  Fisher’s  exact  test.  Continuous
nd  ordinal  variables  are  presented  as  means  ±  standard
eviations  or  medians  (ranges),  and  were  compared
y  the  Mann-Whitney  test.  Survival  probabilities  were
alculated  using  the  Kaplan—Meier  method,  and  were  com-
ared  using  the  log-rank  test.  All  tests  were  two-sided
nd  a P-value  <  0.05  was  considered  statistically  signiﬁ-
ant.
esults
etween  April  2006  and  May  2012,  20  patients  underwent
losure  of  PMI-VSD  in  three  centres  (University  Hospital
f  La  Timone,  Marseille;  University  Hospital  of  Arnaud-
e-Villeneuve,  Montpellier;  le  Millénaire  Private  Hospital,
ontpellier).  The  mean  age  of  the  patients  was  67  (range,
2—85)  years  and  there  were  nine  (45%)  women.  Preexisting
ardiovascular  co-morbid  states  were  hypertension  (n  =  9),
iabetes  (n  =  6),  history  of  smoking  (n  =  9)  and  hypercholes-
erolaemia  (n  =  9).  In  addition,  two  patients  had  a history  of
ngina.
cute myocardial infarction presentation
ost  patients  (n  =  16,  80%)  were  diagnosed  with  AMI  more
han  24  hours  after  onset  of  symptoms.  No  patient  had
ardiogenic  shock  at  presentation.  All  patients  received
tandard  medical  therapy  for  AMI  in  accordance  with  the
ecommendations  [8]. The  AMI  location  was  anterior  in
5%  and  inferior  in  55%.  Single-vessel  disease  was  present
n  coronary  angiography  in  14  (70%)  patients,  while  four
20%)  had  two-vessel  disease  and  two  (10%)  had  triple-vessel
isease.  The  right  coronary  artery  was  most  commonly
nvolved  (n  =  11,  55%),  followed  by  the  left  anterior  des-
ending  artery  (n  =  8,  40%)  and  the  circumﬂex  artery  (n  =  1,
%).  None  of  the  patients  received  intravenous  thrombol-
sis.  All  patients  underwent  cardiac  catheterization  for
oronary  angiography.  Percutaneous  coronary  revascular-atient  underwent  a  coronary  revascularization  procedure
t  the  time  of  surgical  PMI-VSD  closure,  with  a  bypass
raft.  Revascularization  was  not  performed  in  six  (30%)
atients.
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ost-acute myocardial infarction ventricular
eptal defect presentation
he  median  time  from  onset  of  AMI  to  development  of  PMI-
SD  was  6 (range,  3—9)  days.  Right  heart  failure  was  noted
n  nine  (45%)  patients,  severe  left  ventricular  dysfunction
n  six  (30%)  patients  and  biventricular  systolic  dysfunction
n  four  (20%)  patients.  Only  one  patient  had  no  cardiac
ailure  with  normal  biventricular  function.  Acute  cardio-
enic  shock  manifested  with  ventricular  septal  rupture  in
2  (60%)  patients,  11  of  whom  required  intra-aortic  bal-
oon  counterpulsation  (55%),  while  one  was  managed  with
ntravenous  inotropic  therapy.  No  patient  had  disruption
f  atrioventricular  conduction.  Transthoracic  echocardiog-
aphy  was  performed  in  all  patients  on  clinical  suspicion  of
entricular  septal  rupture  (Fig.  1).  The  defect  was  located
n  the  anterior  apical  septum  in  12  (60%)  patients  and  poste-
iorly  in  eight  (40%)  patients.  The  median  VSD  diameter  by
chocardiographic  evaluation  was  18  (range,  12—28)  mm.
o  patient  had  mitral  valve  dysfunction,  papillary  muscle  or
t
d
a
igure 1. Apical four-chamber view showing a large apical post-acute 
yocardial infarction (A). Colour ﬂow mapping demonstrates shunt acr
MPLATZERTM septal occluder device, the 3-year follow-up demonstrate
oppler ﬂow on magniﬁed apical four-chamber view (D).K.R.  Trivedi  et  al.
ree  wall  rupture.  Cardiac  catheterization  was  performed  in
1  patients  with  onset  of  PMI-VSD,  six  of  whom  proceeded
o  device  closure.
anagement of post-acute myocardial
nfarction  ventricular septal defect
edian  time  from  onset  of  AMI  to  ﬁrst  surgical  or  percu-
aneous  closure  procedure  was  18  (range,  4—96)  days.  One
atient  in  the  group  had  protracted  delay  because  of  stroke
ith  haemorrhagic  conversion.  Excluding  this  patient,  the
edian  time  to  closure  of  PMI-VSD  was  17  (range,  4—52)
ays.  Fig.  2 delineates  the  sequential  strategy  undertaken,
ictated  by  clinical  assessment  and  the  general  condition  of
he  patient.Surgical  closure  was  undertaken  in  14  patients.  Con-
raindications  to  undertaking  surgical  closure  (n  =  8)  are
etailed  in  Table  1. Percutaneous  closure  was  attempted  in
ll  and  was  completed  in  six  cases.  One  patient  had  extreme
myocardial infarction ventricular septal defect 42 days after acute
oss the defect (B). After successful device closure with a 24 mm
s a good device position (C) and minimal residual shunt by colour
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Figure 2. Flow diagram showing the sequential procedural manageme
cular septal defect (PMI-VSD).
Table  1  Candidates  (n  =  8)  with  post-acute  myocardial
infarction  ventricular  septal  defect  offered  percutaneous
closure.
Condition
Ischaemic  stroke  with
haemorrhagic  transformation
n =  1
Heparin-induced
thrombocytopoenia
n =  2
Profound  debilitation  n  =  2
Multiple  organ  failure  n  =  2
Patient  declined  surgery  n  =  1
Mean  logistic  EuroSCORE  87.5%  (range,
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Overall,  all-cause  mortality  was  40%,  as  two  patients  died66.5—94.9)
haemodynamic  instability  and  was  returned  from  the  proce-
dure  suite  for  stabilization.  In  the  other  patient,  the  device
could  not  be  placed  optimally  and  was  withdrawn.
Percutaneous  closure  was  performed  under  general
anaesthesia  in  all  but  one  patient,  who  received  local
anaesthesia.  Patients  undergoing  percutaneous  closure  were
older  and  had  a  higher  mean  logistic  EuroSCORE  than  surgi-
cal  patients  (Table  2).  Table  3  details  the  various  devices
used  in  the  patients  who  underwent  percutaneous  closure
as  a  ﬁrst  and  subsequent  closure  procedure.  A  variety  of
devices  were  used,  including  as  many  as  three  devices  in  one
patient  and  two  devices  in  two  patients  (Figs.  1  and  3).  No
procedure-related  complications  or  new  onset/worsening  of
renal  dysfunction  occurred.
Sequential strategyIn  the  surgical  closure  group,  nine  patients  had  important
residual  shunt  (Table  4);  two  of  these  patients  died,  three
were  managed  medically,  three  had  surgical  redo  closure
a
c
gnt of the 20 patients with post-acute myocardial infarction ventri-
nd  one  had  percutaneous  closure.  A  further  intervention
or  important  residual  shunt  was  performed  in  one  patient
fter  the  second  surgical  closure  (Fig.  2).  Devices  used  for
he  second  and  third  closure  are  summarized  in  Table  3.  No
atient  with  percutaneous  closure  required  a  second  closure
rocedure.
rocedural results
urvival  and  residual  shunt  after  the  initial  procedure  are
etailed  in  Table  4.  There  were  no  signiﬁcant  differences
etween  surgical  and  percutaneous  closure,  and  resolution
f  shunt  was  not  associated  with  survival.
Analysing  our  collective  experience  of  managing  PMI-
SD,  25  procedures  were  undertaken  in  20  patients,  not
ncluding  the  abandoned  procedures  (n  =  2).  Of  these,  15
rocedures  were  undertaken  during  the  21  days  of  AMI  pre-
entation.  This  early  closure  group  (<  21  days  after  AMI)  had
 signiﬁcantly  higher  early  mortality  rate,  irrespective  of
losure  strategy.  The  rate  of  early  death  was  also  higher
fter  percutaneous  closure  but  not  after  surgical  closure
Table  5).
Nine  of  the  25  procedures  were  undertaken  6  weeks  after
he  index  AMI,  including  four  as  initial  procedures  (two  sur-
ical,  two  percutaneous)  and  ﬁve  as  additional  procedures
three  surgical,  two  percutaneous).
Survival  to  discharge  home  for  the  entire  pop-
lation  (n  =  20)  was  70%.  Operative  mortality  (death
n  ≤  30  days)  was  30%.  Predicted  operative  mortality  by  logis-
ic  EuroSCORE  for  the  group  (n  =  20)  was  75%.  There  was  a
igniﬁcant  difference  between  predicted  operative  mortal-
ty  and  actual  hospital  mortality  (P  =  0.01).fter  discharge  home.  Kaplan—Meier  cumulative  survival
urves  for  the  surgical  closure  and  percutaneous  closure
roups  are  shown  on  Fig.  4.
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Table  2  Preprocedural  data  in  the  groups  with  surgical  or  percutaneous  closure  as  ﬁrst  treatment.
Surgical  closure
(n  =  14)
Percutaneous  closure
(n  =  6)
P
Age  (years)  64  (55—78)  75  (67—85)  0.01
Logistic  EuroSCORE  (%)  67  (32—93)  87  (66—94)  0.02
Shock  at  presentation  8  4  1.0
Systolic  BP  (mmHg)  99  (75—125)  101  (87—110)  0.56
IACP  9  2  1.0
LVEF  (%) 0.48  (0.35—0.60) 0.48  (0.35—0.60) 1.0
Systolic  PAP  (mmHg) 58  (35—70) 69  (70—86)  0.09
Mean  PAP  (mmHg)  38  (22—60)  51  (33—63)  0.1
Qp/Qs  (n  =  11)  3.26a 3.3b 1.0
Data are mean (range) or number. BP: blood pressure; IACP: intra-aortic counter pulsation; LVEF: left ventricular ejection fraction; PAP:
pulmonary arterial pressure.
a (n = 5).
b (n = 6).
Table  3  AMPLATZERTM devicesa used  for  percutaneous
closure  of  post-acute  myocardial  infarction  ventricular
septal  defect.
Number  Type
First  treatment
Patient  1  3  ASO  24  mm
ASO  18  mm
ACO  35  mm
Patient  2 1  APiVSD  24  mm
Patient  3  1  ACO  25  mm
Patient  4 1  ASO  24  mm
Patient  5 1  ASO  24  mm
Patient  6 1  ASO  24  mm
Second  treatment
Patient  1  2  AmVSD  16  mm
ACO  35  mm
Patient  2  2  ASO  10  mm
ACO  35  mm
ASO: AMPLATZER septal occluder; ACO: AMPLATZER cribriform
occluder; APiVSD: AMPLATZER post-infarction muscular ven-
tricular septal defect occluder; AmVSD: AMPLATZER muscular
ventricular septal defect occluder.
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iscussion
MI-VSD  is  a  life-threatening  complication  of  AMI,  with  a
ortality  rate  exceeding  90%.  In  patients  undergoing  sur-
ical  repair,  mortality  rates  range  from  19%  to  60%  [18].
MI-VSD  is  a  difﬁcult  condition  to  treat,  and  outcome
emains  unsatisfactory,  with  or  without  intervention.  The
rst  surgical  closure  was  performed  by  Cooley  et  al.  in  1957
19].  There  is  a  considerable  body  of  literature  on  surgical
t
d
b
sxperience  of  managing  PMI-VSD,  reﬂecting  the  debate  on
est  time,  best  strategy  and  best  technique  for  obtaining
MI-VSD  closure  and  the  exploration  of  factors  that  may
mpact  outcome.  Many  new  technical  surgical  innovations
ave  been  reported  [20—22].  However,  no  clear  answers
ave  emerged  to  date.  Patient  survival  is  better  when  sur-
ical  PMI-VSD  closure  is  delayed  to  allow  scariﬁcation  of  the
efect  rims  [4,18].  However,  the  rupture  site  can  expand
bruptly,  resulting  in  sudden  haemodynamic  collapse  in  pre-
iously  stable  patients  [1,7,8],  rendering  it  difﬁcult  to  defer
losure.  Whether  to  intervene  remains  a  dilemma.  The  fact
s,  the  onset  of  PMI-VSD  is  an  acute  imposition  of  substan-
ial  cardiac  volume  load  on  the  background  of  severe  left
nd/or  right  ventricular  dysfunction  caused  by  AMI,  in  addi-
ion  to  the  many  co-morbidities  common  to  these  patients.
MI-VSD  is  a  hot  explosive  cauldron  of  not  one,  but  many
iseases.  There  is  overwhelming  acute  duress  of  cardiac
unction  and  haemodynamic  status  with  a  tissue  and  molec-
lar  process  for  a  period  of  3—4  weeks  before  the  disease
imits  are  set.  A  further  period  of  4—6  weeks  follows,  during
hich  scarring  ﬁnally  establishes  ﬁrm  limits  to  the  defect
1,3].  Early  and  emergent  closure  of  PMI-VSD  is  often  nec-
ssary,  even  if  molecular  and  tissue  level  events  are  not
stablished  because  of  the  extent  of  ventricular  septal  loss.
his  is  the  challenge  in  the  management  of  patients  with
MI-VSD.
Percutaneous  closure  of  PMI-VSD  offers  an  interesting
nd  an  attractive  option,  especially  because  of  failure  to
chieve  acceptable  outcome  with  surgical  management  of
he  lesion.  Percutaneous  closure  was  ﬁrst  reported  in  1992
10]. Several  retrospective  studies  [13,14,23,24]  and  one
rospective  study  [11]  are  reported.  There  are  several  limi-
ations  in  the  known  literature.  First,  as  with  surgical  data,
here  is  a  paucity  of  level  1  evidence.  Additionally,  the  study
esigns  are  heterogeneous,  with  different  outcome  varia-
les.  No  study  to  date  presents  data  with  a  contemporary
urgical  control  group.
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Figure 3. Upper left panel: left ventricular angiogram in left anterior oblique projection, showing residual post-acute myocardial infarction
ventricular septal defect (arrow) after initial surgical closure. Upper right panel: 35 mm multifenestrated septal occluder well seated within
the defect with no residual shunt. Middle left panel: 68-year-old patient, 3 weeks after acute myocardial infarction, with important residual
shunt (arrow) after surgical closure. Middle right panel: defect occluded with placement of 24 and 18 mm AMPLATZERTM septal occluders
in addition to 35 mm cribriform occluder. Lower left panel: post-acute myocardial infarction ventricular septal defect (arrow) seen on left
al oc
 righ
wventricular angiogram. Lower right panel: 24 mm AMPLATZERTM sept
is evident on left ventricular angiogram. Failure of expansion of the
Our  data  represent  the  natural  history  and  management
of  this  disease  in  current  times.  We  followed  the  existing
recommendation  to  offer  surgical  closure  as  ﬁrst  treatment
in  the  acuity  of  the  clinical  state  [8].  Percutaneous  closure
w
c
ccluder device deployed in the defect as ﬁrst closure. Residual shunt
t disc is not unusual as a result of intracavitary trabeculations.
as  offered  when  surgical  closure  was  contraindicated  or
hen  the  patient  declined  surgical  closure.  Percutaneous
losure  was  also  offered  if  the  ﬁrst  treatment  (surgi-
al  or  percutaneous)  was  followed  by  a  residual  shunt  of
328  K.R.  Trivedi  et  al.
Table  4  Outcome  of  ﬁrst  closure  procedure  for  post-acute  myocardial  infarction  ventricular  septal  defect.
Surgical  closure
(n  =  14)
Percutaneous  closure
(n  =  6)
Pa
Signiﬁcant  residual  shunt  9  1  0.12
Survival  7  0  0.19
Death  2  1  1.0
Survival  to  discharge  home  11  3  0.3
Without  residual  shunt 4  3  0.19
Death  before  discharge 3  3  0.3
Without  residual  shunt 1  2  1.0
a Fisher’s exact t-test.
Table  5  Residual  shunt  and  early  death  after  early  and  late  closure  procedures  (ﬁrst  and  subsequent).
Early  closurea Late  closureb P
All  procedures  (n  =  15)  (n  =  10)
Signiﬁcant  residual  shunt  9  2  0.09
Early  death  6  1  0.01
Percutaneous  closure  (n  =  3)  (n  =  5)
Signiﬁcant  residual  shunt  1  0  0.375
Early  death  3  0  0.001
Surgical  closure (n =  12)  (n  =  5)
Signiﬁcant  residual  shunt 8  2  0.59
Early  death 3 1  1.0
a < 21 days after index acute myocardial infarction.
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linical  signiﬁcance.  Residual  shunt  is  a  common  occurrence,
iven  the  pathophysiology  of  the  condition.  Closure  was
ttempted  either  by  surgical  or  percutaneous  approach  if
he  residual  shunt  was  of  clinical  signiﬁcance.
Our  data  conﬁrm  the  high  mortality  rate  associated  with
MI-VSD  in  current  times,  albeit  being  much  lower  at  30%.
o  single  approach,  surgical  or  percutaneous,  is  superior  to
he  other  at  the  moment.  Our  approach  led  to  percutaneous
losure  being  offered  to  a  much  sicker  and  older  patient
roup.  This  preselection  may  account  for  the  higher  early
ortality  rate  in  the  percutaneous  closure  group,  although
ortality  rates  in  the  two  groups  did  not  differ  signiﬁcantly.
Our  data  contradict  the  previous  suggestion  that  percu-
aneous  closure  should  be  limited  to  PMI-VSDs  ≤  15  mm  in
ize  [13].  We  were  able  to  place  single  and  multiple  devices
n  defects  as  large  as  28  mm  without  procedural  complica-
ion,  malposition  or  embolization  of  the  device.  This  was
lso  demonstrated  in  a  recent  multicentre  study  from  UK
24].
Our  data  deﬁed  the  estimate  of  outcome  indicated  by
ogistic  EuroSCORE,  notwithstanding  the  known  tendency
f  the  logistic  EuroSCORE  to  overestimate  mortality  rate
25].  Although  the  small  data  set  precludes  a  deﬁnitive
onclusion,  we  can  speculate  that  this  outcome  of  a  lower
ortality  rate  than  that  predicted  by  the  EuroSCORE  may
eﬂect  the  impact  of  the  sequential  strategy  we  pursued  for
losure  of  PMI-VSD.
Figure 4. Kaplan—Meier cumulative survival curves for the groups
with surgical or percutaneous closure as the ﬁrst procedure.
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Our  early  closure  outcome  is  in  keeping  with  the  expe-
rience  of  other  authors  [14,18].  It  is  very  important  to
recognize  that  the  overall  disease  burden  in  these  patients
and  the  very  tenuous  haemodynamic  status  and  pathophy-
siology  we  have  alluded  to  earlier  in  this  section,  are  the
obstacles  in  the  management  of  PMI-VSD.  Therefore  we
agree  with  the  emphasis  placed  by  Assenza  et  al.  [23]  on
avoidance  of  shock  and  multiple  organ  failure  from  very
early  on  after  the  onset  of  PMI-VSD,  and  that  a  gauge  for
multiple  organ  failure  is  a  more  relevant  indicator  of  out-
come.  The  focus  has  to  shift  from  early  closure  versus  late
closure  and  the  impact  of  closure  timing  on  outcome.
Based  on  our  experience,  we  remain  in  support  of  the
current  recommendation  to  pursue  surgical  closure  as  a
ﬁrst  procedure  during  the  acute  state  of  PMI-VSD.  For  a
patient  who  cannot  be  offered  surgical  closure,  we  rec-
ommend  percutaneous  closure  as  ﬁrst  therapy.  Further,  an
expectant  anticipation  of  residual  PMI-VSD  and  the  incum-
bent  haemodynamic  burden  is  required.  The  vigorous  pursuit
of  residual  PMI-VSD  with  percutaneous  closure  as  a  sec-
ond  treatment  is  reasonable.  Interim  management  should
include  decongestive  therapy  for  residual  shunt,  so  that
closure  can  be  deferred  until  an  appropriate  time.  In  the
future,  molecular  changes  and  cardiac  remodelling  in  PMI-
VSD  will  be  better  understood  and  will  allow  reﬁnement  of
the  approach  to  this  high-fatality  condition.
Study  limitations:  our  study  suffers  the  limitations  of  a
retrospective  small  sample  study.  Transcatheter  procedures
were  performed  by  experienced  interventionists  regarding
choice  of  the  device,  use  of  ‘off-label’  devices  and  multiple
implantations.  Consequently,  the  result  of  this  study  may
not  be  generalized.
There  was  no  scope  for  a  valid  comparison  of  percuta-
neous  with  surgical  closure  because  of  the  small  numbers
and  the  protocol  that  offered  surgical  closure  as  the
ﬁrst-intention  therapy  in  accordance  with  current  clinical
practice  recommendations.
Conclusions
The  outcome  of  PMI-VSD  remains  poor  in  current  times.  Sur-
gical  closure  is  the  ﬁrst-intention  therapy.  Transcatheter
closure  is  feasible,  irrespective  of  the  size  of  the  PMI-
VSD  and  the  time  from  the  index  AMI  event;  it  should  be
considered  when  surgical  closure  is  deemed  not  to  be  an
option.  Vigorous  pursuit  of  closure  of  PMI-VSD  in  a  staged
and  a  sequential  manner  is  recommended  based  on  this
experience.  Multicentre  studies  are  indicated  to  reﬁne  the
recommendations.
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